Facebook Pixel Ram Budihal: the man riding the wave | Mint Chennai - newspaper - Bu hikayeyi Magzter.com'da okuyun
Magzter GOLD ile Sınırsız Olun

Magzter GOLD ile Sınırsız Olun

Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin

$149.99
 
$74.99/Yıl

Denemek ALTIN - Özgür

Ram Budihal: the man riding the wave

Mint Chennai

|

August 30, 2025

Ramesh 'Ram' Budihal has solidified his place as one of India's top surfers

- Shail Desai

It was a familiar situation for Ramesh "Ram" Budihal. Two years ago, at an Asian-level surfing competition in Sri Lanka, he had made his first major international final, only to finish fourth and outside the podium places.

Earlier this month, he was minutes away from starting another final, this time at the Asian Surfing Championships in Mahabalipuram. Besides personal glory, there were quota places at stake for the Asian Games in Japan next year. He gazed intently at the waves breaking in the distance, soaking in the sounds of the ocean before embracing the challenge ahead.

"A lot of positive thoughts, where I visualised the things I had worked on and the good days I had experienced in the past. My goal was to simply do it all over again once I stepped into the water," Budihal, 24, recalls.

A bronze at the end of competition marked the first individual medal for an Indian surfer at the event and his best finish in a career spanning over a decade. It also helped the Indian men gather enough points to secure another spot at the Asian Games.

"Just knowing that this was one of Asia's top competitions pushed me hard during the heats. Things didn't go as per plan in the final. Gold was the target, but to get bronze is really incredible considering how I started out. It's the biggest medal of my life so far," he says.

Mint Chennai'den DAHA FAZLA HİKAYE

Mint Chennai

Mint Chennai

Barrier-free tolling runs into a Chinese camera security bump

Commuters looking to zoom past toll plazas on India's 146,560 km highway network will have to wait longer.

time to read

1 min

February 26, 2026

Mint Chennai

A new grammar to challenge Tamil film

Members of the Problematic Family, which premiered at the Berlinale, is a striking, experimental debut film from R. Gowtham

time to read

3 mins

February 26, 2026

Mint Chennai

AUROBINDO PHARMA TAKES A PENICILLIN SHOT

The company has made a ₹2,500 crore bet to rebuild its antibiotic backbone. Will it work?

time to read

6 mins

February 26, 2026

Mint Chennai

Digital rupee pilot for food subsidy

In a significant shift in the way food subsidies are delivered, the government will launch a central bank digital currency (CBDC)-based pilot under the Pradhan Mantri Garib Kalyan Anna Yojana (PMGKAY) in Puducherry on 26 February.

time to read

1 min

February 26, 2026

Mint Chennai

DRL's obesity jab may launch in March

Dr. Reddy's Laboratories (DRL) is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the matter as well as images reviewed by Reuters.

time to read

1 min

February 26, 2026

Mint Chennai

Mint Chennai

Uranium supply deal likely during Carney’s India visit

Cameco CEO Tim Gitzel to be part of the business delegation accompanying Canadian PM

time to read

2 mins

February 26, 2026

Mint Chennai

Mint Chennai

Warner interested in Paramount offer

Warner Bros Discovery Inc. said a new $31-a-share buyout offer from Paramount Skydance Corp. could lead to a better deal than its existing agreement with Netflix Inc., kicking off another potential round of bidding for the famed Hollywood studio.

time to read

1 mins

February 26, 2026

Mint Chennai

Mint Chennai

Hype and havoc shroud Al's impact on IT firms

Is investor anxiety over the business models of IT service companies being rendered obsolete by AI overblown? The truth lies between an apocalypse and AI-impact denial. Here's why

time to read

2 mins

February 26, 2026

Mint Chennai

Mint Chennai

Zydus plans obesity jab in pens after semaglutide patent ends

Ahmedabad-based drugmaker Zydus Lifesciences plans to launch its semaglutide injection brands upon patent expiry of the drug in India.

time to read

1 mins

February 26, 2026

Mint Chennai

Mint Chennai

CHASING 12% EQUITY RETURNS? LONG-TERM INVESTING ISN'T JUST ABOUT A NUMBER

Most investors enter equity mutual funds expecting an annual average return of about 12%.

time to read

3 mins

February 26, 2026

Listen

Translate

Share

-
+

Change font size